SCHEMBL3164704

SCHEMBL3164704

CC(=O)NCCNc1cc(N2CCN(C(=O)c3ccc4[nH]c(C)nc4c3)CC2)nc(-c2ccc(Cl)cc2)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GBA1 P04062 1/20 0.42
MGLL Q99685 7/20 0.42
TP53 P04637 1/20 0.40
MAPT P10636 2/20 0.38
HPGD P15428 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
HRH4 Q9H3N8 1/20 0.38
USP2 O75604 1/20 0.38
CASP1 P29466 1/20 0.38
CASP7 P55210 1/20 0.38
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
SLC6A7 Q99884 1/20 0.36
AURKA O14965 1/20 0.36
PIK3CD O00329 1/20 0.36
PIK3CB P42338 1/20 0.36
MTOR P42345 1/20 0.36
ADORA3 P0DMS8 1/20 0.36
ADORA2A P29274 1/20 0.36
ADORA2B P29275 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3261958 0.92 ADORA2B (0.43) GBA1MGLLMAPTHPGDALDH1A1
SCHEMBL3169097 0.88 SMN1; SMN2 (0.45) GBA1MGLLTP53MAPTHPGD
SCHEMBL3164315 0.86 GBA1 (0.50) GBA1MGLLTP53MAPTHPGD
SCHEMBL3174398 0.85 GBA1 (0.48) GBA1MGLLTP53MAPTHPGD
SCHEMBL3165387 0.85 GBA1 (0.45) GBA1MGLLTP53MAPTHPGD
SCHEMBL3256289 0.84 GBA1 (0.44) GBA1MGLLTP53MAPTHPGD
SCHEMBL3166449 0.84 GBA1 (0.49) GBA1MGLLTP53MAPTHPGD
SCHEMBL3174564 0.84 GBA1 (0.50) GBA1MGLLSMN1; SMN2USP2CASP1
SCHEMBL3164890 0.84 AKR1C3 (0.47) GBA1MAPTHPGDSMN1; SMN2HRH4
SCHEMBL3156444 0.84 GBA1 (0.46) GBA1MAPTHPGDSMN1; SMN2HRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 EP disclosed